Dr Rodrigo Medeiros is a multidisciplinary researcher, with a passion for neuroscience, immunology, genetics and pharmacology. He was educated at the Federal University of Santa Catarina, where he earned a BSc in pharmacy and a MSc and PhD in pharmacology. His PhD thesis focused on the impact of inflammatory process in Alzheimer’s disease. Rodrigo then pursued postdoctoral training at the University of California, Irvine (UCI), where he discovered the fundamental role of muscarinic and calpain signalling pathways in Alzheimer’s disease. He subsequently became a researcher at the UCI Institute for Memory Impairments and Neurological Disorders (UCI MIND) and founded the Neurula Lab. In 2016, Rodrigo brought Neurula to QBI and joined forces with the Clem Jones Centre for Ageing Dementia Research to fight neurodegenerative diseases. The broad goal of the Neurula Lab is to advance knowledge of the healthy and diseased brain to a point where rational strategies can be developed for the early diagnosis, prevention and cure of Alzheimer’s disease and age-related neurodegenerative disorders.